[HTML][HTML] Use of ketamine in patients with refractory severe asthma exacerbations: Systematic review of prospective studies

L La Via, F Sanfilippo, G Cuttone, V Dezio… - European Journal of …, 2022 - Springer
Purpose Asthma is a heterogeneous disease with a wide range of symptoms. Severe
asthma exacerbations (SAEs) are characterized by worsening symptoms and …

[HTML][HTML] Using telemedicine to care for the asthma patient

YK Persaud - Current allergy and asthma reports, 2022 - Springer
Abstract Purpose of Review To review the data supporting the use of telemedicine (TM) and
to provide practical guidance for practitioners to optimize the care of their asthmatic patients …

[HTML][HTML] Severe asthma, telemedicine, and self-administered therapy: listening first to the patient

G Guarnieri, M Caminati, A Achille, R Vaia… - Journal of Clinical …, 2022 - mdpi.com
Severe asthma patients are at an increased risk of major complications and they need to be
monitored regularly. The COVID-19 pandemic has notably impacted on the health care …

[HTML][HTML] Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study

A Benfante, B Sousa-Pinto, G Pillitteri… - International Journal of …, 2022 - mdpi.com
MASK-air®, a good practice of the DG Santé, has been fully validated in allergic rhinitis, but
little is known about its applicability to asthmatics. We explored whether the MASK-air® …

[HTML][HTML] The Asthma Impairment and Risk Questionnaire enhances the assessment of asthma control

B Chipps, RS Zeiger, DA Beuther, J Reibman… - Annals of Allergy …, 2023 - Elsevier
Background Asthma control is often overestimated in routine practice, and despite advances
in the understanding of immunopathology and the availability of new precision therapies, the …

[HTML][HTML] Montelukast and nightmares: further characterisation using data from VigiBase

S Watson, E Kaminsky, H Taavola, M Attalla, QY Yue - Drug Safety, 2022 - Springer
Introduction Montelukast is a medicine indicated for use in asthma. Psychiatric disorders
including nightmares have not been described in clinical trials but during recent years have …

Use of biologic therapies in the treatment of asthma–A comparative real world data analysis on Healthcare resource utilization and costs before and after therapy …

F Hardtstock, J Krieger, T Wilke, M Lukas… - Journal of Asthma …, 2022 - Taylor & Francis
Background Asthma is one of the most common chronic diseases in Germany. While many
patients achieve asthma control under standard therapies, some patients still experience …

[HTML][HTML] Socio-demographics and asthma prevalence, management, and outcomes among children 1–11 years of age in California

JE Banta, M Ramadan, N Alhusseini, K Aloraini… - Global health research …, 2021 - Springer
Background Asthma disproportionately affects minority and low-income children. We
examined asthma prevalence, management and outcomes, focusing on race/ethnicity and …

Picturing asthma in Turkey: results from the Turkish adult asthma registry

GE Celik, O Aydin, D Gokmen, G Koycu Buhari… - Journal of …, 2023 - Taylor & Francis
Introduction National data on asthma characteristics and the factors associated with
uncontrolled asthma seem to be necessary for every country. For this purpose, we …

[HTML][HTML] Development and evaluation of a mobile-based asthma clinical decision support system to enhance evidence-based patient management in primary care

H Abtahi, S Amini, M Gholamzadeh… - Informatics in Medicine …, 2023 - Elsevier
Background Despite tremendous efforts, satisfactory adherence to asthma care guidelines
has remained an unmet need worldwide. There is a growing body of evidence that applying …